Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis

被引：45

作者：

Turza, Kristin ^{[1
]}

Dengel, Lynn T. ^{[1
]}

Harris, Rebecca C. ^{[1
]}

Patterson, James W. ^{[2
]}

White, Kevin ^{[2
]}

Grosh, William W. ^{[3
]}

Slingluff, Craig L., Jr. ^{[1
]}

机构：

[1] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA

[2] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA

[3] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA

来源：

JOURNAL OF CUTANEOUS PATHOLOGY | 2010年 / 37卷 / 01期

关键词：

ISOLATED LIMB PERFUSION; TOPICAL IMIQUIMOD; LENTIGO MALIGNA; SKIN; RECURRENCES; MANAGEMENT;

D O I：

10.1111/j.1600-0560.2009.01290.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Turza K, Dengel L, Harris RC, Patterson JW, White K, Grosh WW, Slingluff CL Jr. Effectiveness of imiquimod limited to dermal melanoma metastases, with simultaneous resistance of subcutaneous metastasis.

引用

页码：94 / 98

页数：5

共 15 条

[1] Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma [J].

Bong, AB ;

Bonnekoh, B ;

Franke, I ;

Schön, MP ;

Ulrich, J ;

Gollnick, H .

DERMATOLOGY, 2002, 205 (02) :135-138

[2] Treatment of lentigo maligna with imiquimod before staged excision [J].

Cotter, Murray A. ;

McKenna, Jeffrey K. ;

Bowen, Glen M. .

DERMATOLOGIC SURGERY, 2008, 34 (02) :147-151

[3]

du Plessis PJ, 2007, S AFR J SURG, V45, P72

[4] Management of extremity recurrences after complete responses to isolated limb perfusion in patients with melanoma [J].

Feldman, AL ;

Alexander, HR ;

Bartlett, DL ;

Fraker, DL ;

Libutti, SK .

ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (06) :562-567

[5]

Fraker D L, 1995, Cancer J Sci Am, V1, P122

[6] Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: Results of a tumor necrosis factor dose-escalation study [J].

Fraker, DL ;

Alexander, HR ;

Andrich, M ;

Rosenberg, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :479-489

[7] Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma [J].

Green, D. S. ;

Bodman-Smith, M. D. ;

Dalgleish, A. G. ;

Fischer, M. D. .

BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) :337-345

[8] Imiquimod in the treatment of lentigo maligna [J].

Rajpar, S. F. ;

Marsden, J. R. .

BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (04) :653-656

[9]

Spenny ML, 2007, CUTIS, V79, P149

[10] Topical imiquimod treatment of a cutaneous melanoma metastasis [J].

Steinmann, A ;

Funk, JO ;

Schuler, G ;

von den Driesch, P .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (03) :555-556

← 1 2 →